AVG.L

Avingtrans Plc
Avingtrans PLC - Exercise of Options, PDMR Dealings & TVR
21st March 2024, 17:15
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8578H
Avingtrans PLC
21 March 2024
 

21 March 2024

Avingtrans Plc

 

("Avingtrans", the "Company", or the "Group")

 

Exercise of Options, PDMR Dealings and Total Voting Rights

 

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces transactions involving its shares by certain PDMRs and other employees pursuant to the Company Share Option plan ("CSOP").

 

On 20 March 2024, the Company was notified of the exercise of 192,400 CSOP options over ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the Company's FY 2019 CSOP and FY 2020 CSOP.

 

Details of the exercise of options by PDMRs, together with subsequent beneficial holdings of each individual following the transactions, are set out below:

 

PDMR / Role

CSOP options exercised

Beneficial interest in Ordinary Shares following the transactions

Resulting percentage holding of Enlarged Total Voting Rights held

Stephen King (CFO)

10,400

417,338

1.27%

Austen Adams (MD, Process Solutions & Rotating Equipment)

110,000

263,135

0.80

 

Issue of Equity

 

Application has been made for the admission to trading on AIM for the 192,400 new Ordinary Shares ("Admission"). It is expected that Admission will become effective on 26 March 2024.

 

Total Voting Rights

 

Following the issue of the 192,400 new Ordinary Shares, the Company will have a total of 33,089,922 Ordinary Shares in issue. The Company does not hold any shares in Treasury.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The above information is provided by the Company in accordance with its obligations under the FCA's Disclosure Guidance and Transparency Rules.

 

ENDS

 

 

Enquiries:

 

Avingtrans plc

Les Thomas, Interim Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

01354 692391

Singer Capital Markets (Nominated Adviser and Broker)

Shaun Dobson

Alex Bond

Oliver Platts

 

02074 963000

IFC Advisory (Financial PR)

Graham Herring

Tim Metcalfe

Zach Cohen

020 3934 6630

 

 

 

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

Business units

Hayward Tyler - Luton, East Kilbride & Nottingham, UK, USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments. 

Energy Steel, Inc - Rochester Hills, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support. 

Stainless Metalcraft Ltd - Chatteris, UK

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems. 

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.

Ormandy Group - Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products. 

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Adaptix Ltd - Oxford, UK

Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going.

 

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units: 

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

Tecmag Inc - Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Steve King

2

 

Reason for the notification

 

a)

 

Position/status

 

 

CFO

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

CSOP Option Awards over Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Exercise of Options under the CSOP

 

c)

 

Price(s) and volume(s)


 

Price(s)

Volume(s)

267p

10,400

 

 

 

 

 

 







d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

20 March 2024

f)

 

Place of the transaction

 

 

Off market

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Austen Adams

2

 

Reason for the notification

 

a)

 

Position/status

 

 

MD, Process Solutions & Rotating Equipment

 

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Avingtrans PLC

b)

 

LEI

 

 

213800ZZ96CKPI423E86

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

CSOP Option Awards over Ordinary Shares of 5p each



Identification code

ISIN: GB0009188797

 



b)

 

Nature of the transaction

 

 

Exercise of Options under the CSOP

 

c)

 

Price(s) and volume(s)


 

Price(s)

Volume(s)

267p

110,000

 

 

 

 

 

 







d)

 

Aggregated information

n/a



- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

20 March 2024

f)

 

Place of the transaction

 

 

Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFERVTILFIS]]>
TwitterFacebookLinkedIn